Universal Infant Nirsevimab Rollout Linked to 71 Percent Drop in RSV Hospitalizations
A population-based observational study in Puglia, Italy, found universal infant immunization with nirsevimab was associated with a 71 percent decline ...
A population-based observational study in Puglia, Italy, found universal infant immunization with nirsevimab was associated with a 71 percent decline ...
A pharmacovigilance study found disproportionately higher rates of vascular ectasia and regional bleeding reports with sotatercept compared to other pulmonary ...
A multicenter clinical trial found that once-daily atinvicitinib safely and effectively reduced pruritus and dermatitis severity in dogs with allergic ...
A pharmacovigilance analysis of FDA adverse event reports identified a significant interstitial lung disease safety signal linked to the interleukin-1β ...
A text-mining analysis of FDA MAUDE reports from 2018 to 2024 reveals that MRI safety incidents increasingly involve medical implants, ...
An evaluation of the ovarian cancer cohort in the FICOG VIP study demonstrated that the Patient-Reported Outcomes version of the ...
A secondary analysis of a phase I leukemia trial cohort found that patient-reported outcomes revealed substantial symptom burden beyond clinician-graded ...
A twelve-year retrospective analysis of Israel’s medical device registry found that annual adverse event and safety notice reports rose from ...
A scoping review of 13 clinical studies found that 1064 nm Nd:YAG lasers achieved basal cell carcinoma clearance rates between ...
A pharmacovigilance study reveals combining immune checkpoint inhibitors with chemotherapy brings earlier adverse events alongside lower reported mortality odds than ...
© 2026 Scienmag - Science Magazine
© 2026 Scienmag - Science Magazine